Literature DB >> 12748883

CSF shunt infections in children: experiences from a population-based study.

P Ø Enger1, F Svendsen, K Wester.   

Abstract

UNLABELLED: The objective was to identify risk factors for shunt infections, and establish the rate of infection for shunt procedures carried out under standardized conditions in a well-defined population. All (407) paediatric shunt operations (primary and revisions) performed within a total population of 630000 inhabitants between January 1, 1986 and December 31, 1996, were analysed retrospectively. 11 shunt infections were diagnosed in 10 patients, giving an overall infection rate of 2.7% per procedure and 6.2% per patient. Infections were significantly correlated with age, type of operation, and a etiology of hydrocephalus. Thus, infections occurred more frequently during the first 6 months of life, more often following primary shunt insertions compared with revisions, and children with myelomeningocele had a higher infection risk than children with hydrocephalus due to other causes. There was a highly significant male preponderance in the patient material.
CONCLUSION: The overall infection rate was relatively low. The risk factors for shunt infections appear to relate to epidemiological characteristics rather than to surgical factors.

Entities:  

Mesh:

Year:  2003        PMID: 12748883     DOI: 10.1007/s00701-002-1068-5

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  20 in total

1.  CSF fistula through the left lumbar region in adult following a ventriculoperitoneal shunt surgery: a rare case report.

Authors:  Shi-yin Xiao; Lu Ma; Bal Krishna Shrestha; Yue-kang Zhang; Bo-Yong Mao
Journal:  Neurol Sci       Date:  2010-05-08       Impact factor: 3.307

2.  Third ventriculostomy vs ventriculoperitoneal shunt in pediatric obstructive hydrocephalus: results from a Swiss series and literature review.

Authors:  Sandrine de Ribaupierre; B Rilliet; O Vernet; L Regli; J-G Villemure
Journal:  Childs Nerv Syst       Date:  2007-01-17       Impact factor: 1.475

3.  The impact of antibiotic-impregnated catheters on shunt infection in children and neonates.

Authors:  Caroline Hayhurst; Richard Cooke; Dawn Williams; Jothy Kandasamy; Donncha F O'Brien; Conor L Mallucci
Journal:  Childs Nerv Syst       Date:  2007-10-26       Impact factor: 1.475

Review 4.  Shunt infections: a review and analysis of a personal series.

Authors:  Santosh Mohan Rao Kanangi; Chidambaram Balasubramaniam
Journal:  Childs Nerv Syst       Date:  2018-07-05       Impact factor: 1.475

5.  Microbiology and treatment of cerebrospinal fluid shunt infections in children.

Authors:  Daniel J Adams; Michael Rajnik
Journal:  Curr Infect Dis Rep       Date:  2014-10       Impact factor: 3.725

6.  Analysis of factors affecting ventriculoperitoneal shunt survival in pediatric patients.

Authors:  Farid Khan; Muhammad Shahzad Shamim; Abdul Rehman; Muhammad Ehsan Bari
Journal:  Childs Nerv Syst       Date:  2013-01-08       Impact factor: 1.475

Review 7.  Is there an ideal shunt? A panoramic view of 110 years in CSF diversions and shunt systems used for the treatment of hydrocephalus: from historical events to current trends.

Authors:  Nigel Peter Symss; Shizuo Oi
Journal:  Childs Nerv Syst       Date:  2014-12-30       Impact factor: 1.475

Review 8.  Antibiotic prophylaxis for shunt surgery of children: a systematic review.

Authors:  H Xu; F Hu; H Hu; W Sun; W Jiao; R Li; T Lei
Journal:  Childs Nerv Syst       Date:  2015-10-23       Impact factor: 1.475

9.  Surgical treatment of myelomeningocele: year 2000 hospitalization, outcome, and cost analysis in the US.

Authors:  Anthony H Sin; Mahmoud Rashidi; Gloria Caldito; Anil Nanda
Journal:  Childs Nerv Syst       Date:  2007-06-06       Impact factor: 1.475

10.  Hydrocephalus in children born in 1999-2002: epidemiology, outcome and ophthalmological findings.

Authors:  Eva-Karin Persson; Susann Anderson; Lars-Martin Wiklund; Paul Uvebrant
Journal:  Childs Nerv Syst       Date:  2007-04-12       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.